GORACCI, ARIANNA
 Distribuzione geografica
Continente #
EU - Europa 10.554
NA - Nord America 8.745
AS - Asia 3.566
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 309
AF - Africa 235
OC - Oceania 29
Totale 24.029
Nazione #
US - Stati Uniti d'America 8.602
RU - Federazione Russa 3.251
IT - Italia 2.283
GB - Regno Unito 1.788
CN - Cina 1.232
SG - Singapore 1.186
IE - Irlanda 855
SE - Svezia 483
BR - Brasile 479
UA - Ucraina 447
FR - Francia 353
DE - Germania 308
HK - Hong Kong 278
VN - Vietnam 274
PL - Polonia 210
FI - Finlandia 184
ZA - Sudafrica 123
ES - Italia 121
KR - Corea 121
IN - India 118
NL - Olanda 97
CA - Canada 80
JP - Giappone 73
BD - Bangladesh 51
IQ - Iraq 41
TR - Turchia 41
MX - Messico 40
AR - Argentina 39
NG - Nigeria 29
AU - Australia 27
CH - Svizzera 27
PK - Pakistan 22
AT - Austria 20
BE - Belgio 19
EC - Ecuador 17
GR - Grecia 17
IR - Iran 16
MY - Malesia 16
CI - Costa d'Avorio 14
VE - Venezuela 14
CZ - Repubblica Ceca 12
EG - Egitto 12
MA - Marocco 12
PT - Portogallo 11
SA - Arabia Saudita 11
KE - Kenya 10
RO - Romania 10
UY - Uruguay 10
CL - Cile 9
CO - Colombia 9
JO - Giordania 9
TW - Taiwan 9
BG - Bulgaria 8
DK - Danimarca 8
ID - Indonesia 8
PH - Filippine 8
UZ - Uzbekistan 8
HU - Ungheria 7
KZ - Kazakistan 6
PE - Perù 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
PY - Paraguay 5
UG - Uganda 5
AE - Emirati Arabi Uniti 4
GT - Guatemala 4
LU - Lussemburgo 4
NO - Norvegia 4
TH - Thailandia 4
ET - Etiopia 3
EU - Europa 3
JM - Giamaica 3
LT - Lituania 3
MD - Moldavia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
SI - Slovenia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AM - Armenia 1
Totale 23.697
Città #
Southend 1.609
Dublin 844
Ashburn 828
Dallas 794
Fairfield 748
Singapore 620
Houston 585
Chandler 470
Santa Clara 415
Moscow 385
Woodbridge 372
San Jose 361
Jacksonville 352
Beijing 334
Milan 310
Seattle 287
Wilmington 275
Hong Kong 263
Cambridge 245
Ann Arbor 208
Council Bluffs 198
Hefei 167
Rome 167
Siena 167
Princeton 150
The Dalles 148
Los Angeles 117
Seoul 115
Johannesburg 111
Nanjing 108
Helsinki 99
Málaga 89
Lauterbourg 86
Florence 84
Ho Chi Minh City 71
New York 70
San Mateo 70
Warsaw 69
Boardman 65
Washington 58
Hanoi 57
Dong Ket 52
Munich 49
Columbus 48
Orem 46
Nanchang 43
San Diego 43
Buffalo 41
Naples 39
São Paulo 39
Tianjin 38
Menlo Park 35
London 32
Turin 32
Chennai 31
Brooklyn 30
Shenyang 30
Bologna 29
Norwalk 29
Abuja 28
Palermo 26
Chicago 25
Hebei 23
Redondo Beach 23
Tokyo 23
Dearborn 22
Jiaxing 22
San Francisco 22
Montreal 20
Prato 20
Toronto 19
Belo Horizonte 18
Brussels 18
Figino 18
Frankfurt am Main 18
Stockholm 18
Bengaluru 17
Kunming 17
Brescia 16
Catania 16
Changsha 16
Jinan 16
Rio de Janeiro 16
Shanghai 16
Trento 16
Turku 16
Verona 16
Fremont 15
Mumbai 15
Nuremberg 15
Redwood City 15
Abidjan 14
Da Nang 14
Guangzhou 14
Krakow 14
Boston 13
Cagliari 13
Curitiba 13
Pisa 13
Zhengzhou 13
Totale 13.979
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.709
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 535
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 472
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 419
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 418
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 378
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 340
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 312
Mood stabilisers and pregnancy outcomes - a review 295
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 293
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 290
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 285
P.1.k.034 Psychomotor agitation in emergency medicine settings 284
Drug safety evaluation of aripiprazole in bipolar disorder 280
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 274
Liraglutide in psychiatric patients: preliminary results 269
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 267
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 267
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 266
Mood disorders and bariatric surgery: a pilot study 261
Telepsychiatry: new perspectives and open issues 259
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 257
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 249
Early warning symptoms of schizophrenia 247
Advances in treatment for postpartum major depressive disorder 246
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 242
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 240
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 239
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 239
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 234
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 234
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 232
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 230
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 230
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 229
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 228
Infertility and psychiatric morbidity 225
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 223
Quality of life, anxiety and depression in Sarcoidosis 221
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 218
Quality of life and sub threshold affective symptoms 215
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 214
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 212
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 212
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 210
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 209
Clinica della mania 208
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 208
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 208
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 203
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 203
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 200
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 198
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 197
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 197
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 195
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 194
Quality of life and subthreshold obsessive-compulsive disorder 192
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 190
Spettro dell'umore e sindrome metabolica 187
Accuracy of self-assessment of real-life functioning in schizophrenia 187
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 186
The long term-maximising potential for rehabilitation in patients with schizophrenia 185
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 183
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 182
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 182
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 181
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 180
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 178
Social cognition in people with schizophrenia: a cluster-analytic approach 178
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 178
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 174
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 171
Pharmacotherapy of binge-eating disorder: a review 171
Quetiapine in post-transplant acute mania/bipolar disorder NOS 169
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 165
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 159
null 155
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 154
Psicopatologia della mania: dimensioni fenomenologiche 152
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 152
What can we learn from the large US Cohort study (STEP-BD) 148
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 146
Binge eating disorder: from clinical research to clinical practice 144
Practical guidance for prescribing trazodone extended-release in major depression 140
Human CRY1 variants associate with attention deficit/hyperactivity disorder 139
Physical activity and mental health, psychological and physiological mechanisms 135
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 134
null 134
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 133
Interazione tra farmaci 130
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 129
Pharmacokinetic Interactions 122
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 122
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 120
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 114
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 114
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 107
null 106
null 100
Totale 23.727
Categoria #
all - tutte 68.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.140 0 0 123 135 97 47 88 101 129 119 71 230
2022/20233.864 98 141 247 239 172 330 62 192 2.119 117 89 58
2023/20241.934 80 55 188 100 140 501 509 64 29 62 80 126
2024/20253.188 97 201 280 259 392 230 118 132 324 140 343 672
2025/20266.306 566 813 546 647 1.270 245 715 234 268 347 190 465
2026/2027553 238 223 92 0 0 0 0 0 0 0 0 0
Totale 24.029